Robert A Wade | Researchain

Archive Network Publication Hotspot Collaboration

Network

Latest external collaboration on country level. Dive into details by clicking on the dots.

Explore More

Hotspot

Dive into the research topics where Robert A Wade is active.

Explore More

Publication

Featured researches published by Robert A Wade.

Archive | 1996

Crystalline [R- (R,R)]-2-(4-Dfluorophenyl)-β,δ-dihydroxy-5-(1-methylethyl)- 3-phenyl-4-[(phenylamino)carbonyl]-1H-pyrrole-1-heptanoic acid hemi calcium salt (atorvastatin)

Christopher A Briggs; Rex Allen Jennings; Robert A Wade; Kikuko Harasawa; Shigeru Ichikawa; Kazuo Minohara; Shinsuke Nakagawa

Journal of Organic Chemistry | 2003

An enantioselective synthesis of (S)-(+)-3-aminomethyl-5-methylhexanoic acid via asymmetric hydrogenation.

Mark J. Burk; Pieter D. de Koning; Todd Michel Grote; Marvin Simon Hoekstra; Garrett Hoge; Rex Allen Jennings; William Kissel; Tung V. Le; Ian C. Lennon; Thomas Arthur Mulhern; James Andrew Ramsden; Robert A Wade

Archive | 1996

Crystalline R-(R,R)

Christopher A Briggs; Kikuko Harasawa; Shigeru Ichikawa; Rex Allen Jennings; Kazuo Minohara; Shinsuke Nakagawa; Robert A Wade

Organic Process Research & Development | 1997

-2-(4-fluorophenyl)-beta,delta-dihydroxy-5-(1-methylethyl)-3-phenyl-4- (phenylamino)carbonyl -1H-pyrrole-1-heptanoic acid hemi calcium salt (atorvastatin)

Robert A Wade; Thomas M. Zennie; Christopher A Briggs; Rex Allen Jennings; Thomas N. Nanninga; and Charles W. Palmer; Ronald J. Clay

Tetrahedron Letters | 2011

In Pursuit of Higher Purity: Use of 13C NMR and 13C-Enriched Substrates To Trace Impurity Generation and Removal in the Synthesis of Atorvastatin

Charles Boos; Daniel Merritt Bowles; Cuiman Cai; Agustin Casimiro-Garcia; Xiangyang Chen; Catherine A. Hulford; Sandra M. Jennings; E. Jason Kiser; David W. Piotrowski; Matthew F. Sammons; Robert A Wade

Archive | 1996

Synthesis and cross coupling of a highly substituted 2-pyridylboronate: application to the large scale synthesis of a mineralocorticoid antagonist

Christopher A Briggs; Kikuko Harasawa; Hayashi Ichikawa; Rex Allen Jennings; Kazuo Minohara; Shinsuke Nakagawa; Robert A Wade; ウエード，ロバート・エイ; ジエニングズ，レツクス・アレン; ブリツグズ，クリストフアー・エイ; 真介中川; 喜久子原沢; 林市川; 一雄蓑原

Archive | 2013

Crystalline ⅲ type [r- (r , r )] - 2- (4-fluorophenyl) -beta, delta-dihydroxy-5- (1-methylethyl) -3-phenyl-4 - [( phenylamino) carbonyl] -1h- pyrrol-1-heptanoic acid hemi calcium salt (atorvastatin)

Christopher A Briggs; ブリツグズ，クリストフアー・エイ; Rex Allen Jennings; ジエニングズ，レツクス・アレン; Robert A Wade; ウエード，ロバート・エイ; Kikuko Harasawa; 喜久子原沢; Hayashi Ichikawa; 林市川; Kazuo Minohara; 一雄蓑原; Shinsuke Nakagawa; 真介中川

Archive | 2011

PROCESS FOR PREPARATION OF CRYSTALLINE [R-(R,R)]-2-(4-FLUOROPHENYL)-β,δ-DIHYDROXY-5-(1-METHYLETHYL)-3-PHENYL-4-[(PHENYLAMINO)CARBONYL]-1H-PYRROLE-1-HEPTANOIC ACID (ATORVASTATIN)

Archive | 2011

METHOD FOR PRODUCING CRYSTALLINE [R-(R,R)]-2-(4-FLUOROPHENYL)-β,δ-DIHYDROXY-5-(1-METHYLETHYL)-3-PHENYL-4-[(PHENYLAMINO)CARBONYL]-1H-PYRROLE-1-HEPTANOIC ACID (ATORVASTATIN)

Abstracts of Papers American Chemical Society | 2006

結晶性の〔Ｒ−（Ｒ＊，Ｒ＊）〕−２−（４−フルオロフェニル）−β，δ−ジヒドロキシ−５−（１−メチルエチル）−３−フェニル−４−〔（フェニルアミノ）カルボニル〕−１Ｈ−ピロール−１−ヘプタン酸（アトルバスタチン）の製法

Rex Allen Jennings; William Kissel; Tung V. Le; Edward A. Lenoir; Thomas Mulhern; Robert A Wade

Explore More

Collaboration

Dive into the Robert A Wade's collaboration.

Top Co-Authors

Rex Allen Jennings

Pfizer

View shared research outputs

Top Co-Authors

Tung V. Le

Pfizer

View shared research outputs

Top Co-Authors

William Kissel

Pfizer

View shared research outputs

Top Co-Authors

Agustin Casimiro-Garcia

Pfizer

View shared research outputs

Top Co-Authors

Catherine A. Hulford

Pfizer

View shared research outputs

Top Co-Authors

Charles Boos

Pfizer

View shared research outputs

Top Co-Authors

Cuiman Cai

Pfizer

View shared research outputs

Top Co-Authors

Daniel Merritt Bowles

Pfizer

View shared research outputs

Top Co-Authors

David W. Piotrowski

Pfizer

View shared research outputs

Top Co-Authors

E. Jason Kiser

Pfizer

View shared research outputs

Explore More

Archive Network Publication Hotspot Collaboration

Network

Latest external collaboration on country level. Dive into details by clicking on the dots.

Hotspot

Dive into the research topics where Robert A Wade is active.

Publication

Featured researches published by Robert A Wade.

Crystalline [R- (R*,R*)]-2-(4-Dfluorophenyl)-β,δ-dihydroxy-5-(1-methylethyl)- 3-phenyl-4-[(phenylamino)carbonyl]-1H-pyrrole-1-heptanoic acid hemi calcium salt (atorvastatin)

An enantioselective synthesis of (S)-(+)-3-aminomethyl-5-methylhexanoic acid via asymmetric hydrogenation.

Crystalline R-(R*,R*)

-2-(4-fluorophenyl)-beta,delta-dihydroxy-5-(1-methylethyl)-3-phenyl-4- (phenylamino)carbonyl -1H-pyrrole-1-heptanoic acid hemi calcium salt (atorvastatin)

In Pursuit of Higher Purity: Use of 13C NMR and 13C-Enriched Substrates To Trace Impurity Generation and Removal in the Synthesis of Atorvastatin

Synthesis and cross coupling of a highly substituted 2-pyridylboronate: application to the large scale synthesis of a mineralocorticoid antagonist

Crystalline ⅲ type [r- (r *, r *)] - 2- (4-fluorophenyl) -beta, delta-dihydroxy-5- (1-methylethyl) -3-phenyl-4 - [( phenylamino) carbonyl] -1h- pyrrol-1-heptanoic acid hemi calcium salt (atorvastatin)

PROCESS FOR PREPARATION OF CRYSTALLINE [R-(R*,R*)]-2-(4-FLUOROPHENYL)-β,δ-DIHYDROXY-5-(1-METHYLETHYL)-3-PHENYL-4-[(PHENYLAMINO)CARBONYL]-1H-PYRROLE-1-HEPTANOIC ACID (ATORVASTATIN)

METHOD FOR PRODUCING CRYSTALLINE [R-(R*,R*)]-2-(4-FLUOROPHENYL)-β,δ-DIHYDROXY-5-(1-METHYLETHYL)-3-PHENYL-4-[(PHENYLAMINO)CARBONYL]-1H-PYRROLE-1-HEPTANOIC ACID (ATORVASTATIN)

Collaboration

Dive into the Robert A Wade's collaboration.

Crystalline [R- (R,R)]-2-(4-Dfluorophenyl)-β,δ-dihydroxy-5-(1-methylethyl)- 3-phenyl-4-[(phenylamino)carbonyl]-1H-pyrrole-1-heptanoic acid hemi calcium salt (atorvastatin)

Crystalline R-(R,R)

Crystalline ⅲ type [r- (r , r )] - 2- (4-fluorophenyl) -beta, delta-dihydroxy-5- (1-methylethyl) -3-phenyl-4 - [( phenylamino) carbonyl] -1h- pyrrol-1-heptanoic acid hemi calcium salt (atorvastatin)

PROCESS FOR PREPARATION OF CRYSTALLINE [R-(R,R)]-2-(4-FLUOROPHENYL)-β,δ-DIHYDROXY-5-(1-METHYLETHYL)-3-PHENYL-4-[(PHENYLAMINO)CARBONYL]-1H-PYRROLE-1-HEPTANOIC ACID (ATORVASTATIN)

METHOD FOR PRODUCING CRYSTALLINE [R-(R,R)]-2-(4-FLUOROPHENYL)-β,δ-DIHYDROXY-5-(1-METHYLETHYL)-3-PHENYL-4-[(PHENYLAMINO)CARBONYL]-1H-PYRROLE-1-HEPTANOIC ACID (ATORVASTATIN)